Karnataka: 49.35 kg banned stimilant drug seized by NCB, 2 held

Published On 2021-01-22 03:30 GMT   |   Update On 2021-01-22 12:51 GMT

Bengaluru: In a joint operation with its counterparts in Chennai zone, Narcotics Control Bureau's Bengaluru Zone officials on Thursday busted a drugs racket by arresting two persons and seizing 49.5 kg banned stimulant chemical Ephedrine.

The contraband was concealed in electric commercial sandwich-makers and other electrical accessories, a statement by Bengaluru NCB office said. The arrested accused are M Mydeen and K Meeran.

"These accused are experts in concealing drugs in cavities of various kitchen utensils and appliances. The first trail of the crime was found in Hyderabad, when the NCB seized 4.35 kg Methaqualone at a courier service centre. Based on the lead, the Chennai NCB arrested the two accused and seized 45 kg contraband at Chengalpattu in Tamil Nadu," the statement said.

According to an NCB officer, Ephedrine is used by manufacturers of detergents, perfumes and dyes, apart from anti-asthmatic drugs. It is banned in many countries due to its side-effects, but has a huge demand in countries like Australia, South Africa, and African and South-East Asian countries.

Read also:RAID: Drugs, heroin worth Rs 30 lakh seized in Delhi, 1 arrested

In South Africa, possessing more than eight mg of the drug by an individual is punishable under anti-drugs laws. "But still, such drugs are clandestinely routed to these countries," the NCB said.


Tags:    
Article Source : IANS

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News